| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $786.9M | +3.7% |
| Cost of Revenue | $529.8M | +0.3% |
| Gross Profit | $257.1M | +11.6% |
| R&D Expense | $7.7M | +1.3% |
| SG&A Expense | $213.3M | -5.2% |
| Operating Income | $62.8M | +314.2% |
| Interest Expense | $3.6M | -7.7% |
| Pre-tax Income | $23.7M | +140.9% |
| Income Tax | $4.3M | -17.4% |
| Net Income | $19.4M | +131.5% |
| EPS (Basic) | $0.95 | +131.1% |
| EPS (Diluted) | $0.95 | +131.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.3M | +7.3% |
| Accounts Receivable | $109.8M | +9.6% |
| Inventory | $139.8M | +13.3% |
| Current Assets | $431.6M | +9.5% |
| Total Assets | $1.01B | -0.6% |
| Current Liabilities | $194.1M | +0.3% |
| Long-term Debt | $496.5M | +9268.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$821K | -107.9% |
| Capital Expenditures | $22.0M | +49.1% |
| Investing Cash Flow | $37.5M | +1488.0% |
| Financing Cash Flow | -$26.5M | -129.6% |
| Free Cash Flow | -$22.8M | -430.6% |
| Stockholders' Equity |
| $159.0M |
| +18.9% |